Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.69 | 32.50 |
| PEG Ratio (TTM) | -0.49 | 5.87 |
| P/S Ratio (TTM) | 0.66 | 5.17 |
| P/B Ratio (TTM) | 1.20 | 9.42 |
| P/FCF Ratio (TTM) | 10.90 | 24.17 |
| Price to 5YR AVG Earnings Ratio | 23.52 | 33.57 |
| Price to 5YR AVG FCF Ratio | -560.51 | 75.53 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.04% | 5.42% |
| ROE (TTM) | -19.61% | 21.15% |
| Net Profit Margin (TTM) | -11.58% | -28.14% |
| ROIC 5YR AVG | 2.52% | 91.95% |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -35.23% | 2,447.01% | 1,389.87% |
| Revenue | 2.60% | 7.14% | 10.91% |
| Net Income | -35.84% | 2,529.60% | 1,439.93% |
| Cash Flow | 252.09% | -14.83% | 38.57% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.60 | 1.99 |
| Quick Ratio (TTM) | 0.78 | 1.45 |
| D/E Ratio (TTM) | 0.30 | 1.29 |
| Interest Coverage (TTM) | N/A | 16.89 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 1.62 | 4.36 |
| LTL to 5YR AVG FCF | -409.90 | 6.35 |
| Shares Outstanding Growth 5YR AVG | 1.48% | 11.16% |